Hee-Jeong Cho
Overview
Explore the profile of Hee-Jeong Cho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee S, Cho H, Moon J, Jung J, Kim M, Heo M, et al.
Korean J Intern Med
. 2025 Jan;
40(1):115-123.
PMID: 39778530
Background/aims: Multiple myeloma (MM) predominantly affects elderly individuals, but studies on older patients with MM are limited. The clinical characteristics and survival outcomes of patients with MM aged 80 years...
2.
Prognostic impact of F-FDG PET/CT in patients with multiple myeloma presenting with renal impairment
Ahn S, Park H, Moon J, Baek D, Cho H, Sohn S, et al.
Int J Hematol
. 2021 Jan;
113(5):668-674.
PMID: 33475961
Renal insufficiency (RI) is a frequent manifestation of multiple myeloma (MM) at time of diagnosis but there is no reliable prognostic factor for patients with MM presenting with RI. This...
3.
Cho H, Seo S, Baek D, Park S, Lee Y, Sohn S, et al.
Yeungnam Univ J Med
. 2019 Oct;
35(1):76-83.
PMID: 31620574
Background: Elderly patients with multiple myeloma (MM) are vulnerable to adverse events (AEs). This study evaluated adherence to chemotherapy and treatment outcomes in elderly patients treated with a frontline bortezomib...
4.
Han S, Kim M, Lee S, Cho H, Byun Y, Kim S, et al.
J Appl Toxicol
. 2012 Sep;
33(12):1474-83.
PMID: 22987290
Human endogenous retrovirus (HERV) envelope protein-coated, baculovirus vector-based HPV 16 L1 (AcHERV-HPV16L1) is a non-replicating recombinant baculoviral vaccine. Here, we report an initial evaluation of the preclinical safety of AcHERV-HPV16L1...
5.
Cho H, Lee S, Im S, Kim M, Lee J, Lee H, et al.
Pharm Res
. 2011 Sep;
29(2):585-93.
PMID: 21948385
Purpose: Test pharmacokinetics and biodistribution of a human papillomavirus(HPV)16L1 DNA vaccine delivered in human endogenous retrovirus envelope protein (HERV)-expressing baculovirus (AcHERV) and those of naked plasmid vaccine. Method: HPV16L1 gene...
6.
Kang S, Cho H, Shim G, Lee S, Kim S, Choi H, et al.
Pharm Res
. 2011 Sep;
28(12):3069-78.
PMID: 21879387
Purpose: To test whether co-delivery of anticancer small interfering RNA (siRNA) and a chemical MEK inhibitor using cationic liposomes enhances anticancer activity in vitro and in vivo. Method: MEK inhibitor...
7.
Cho H, Han S, Im S, Lee Y, Kim Y, Chun T, et al.
Biomaterials
. 2011 Mar;
32(20):4621-9.
PMID: 21440296
To improve vaccine delivery, we herein designed a co-delivery system using a protein antigen and its encoding plasmid linked in nanocomplexes via maltosylated PEI (mPEI). Cationic mPEI was electrostatically complexed...
8.
Cho H, Oh Y, Kim Y
Expert Opin Ther Pat
. 2011 Jan;
21(3):295-309.
PMID: 21250872
Introduction: Human papilloma virus (HPV) infection is the main factor associated with the development of cervical cancer. The currently available HPV vaccines, Gardasil and Cervarix, can prevent infection by certain...
9.
Kim E, Cho H, Park D, Kim J, Kim Y, Park T, et al.
Mol Ther
. 2010 Dec;
19(2):355-61.
PMID: 21139571
The imbalanced expression of matrix metalloproteinases (MMPs) is associated with liver fibrosis, one of the most common chronic liver diseases. Enhanced expression of MMPs by gene therapy is emerging as...
10.
Cho H, Kim J, Lee Y, Kim J, Kim Y, Chun T, et al.
Vaccine
. 2010 Feb;
28(14):2598-606.
PMID: 20116467
Needle-free nonparenteral vaccines offer a number of practical advantages, especially in developing countries. To address the effects of vaccine administration route, we tested mucosal and systemic immune responses against human...